CAT# | CPM-1-0336 |
Sequence | GLADQLIHL |
Size | 50 Test, 100 Test | Antigen | Virus HIV | Epitope Origin | HIV Vif | MHC Restriction | HLA-A_02_01 | Conjugate | BV421 |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0249 | HLA-A_24_02 HIV nef 134-141 tetramer-RYPLTFGW-PE labeled | Inquiry | ||
CPM-1-0161 | HLA-B_07_02 P2X5 tetramer-TPNQRQNVC-PE labeled | Inquiry | ||
CPM-1-0275 | HLA-A_02_01 Mtb Ag85A48-56 tetramer-GLPVEYLQV-PE labeled | Inquiry | ||
CPM-1-0786 | HLA-A_24_02 RPL3 KFI tetramer-KFIDTTSKF-PE labeled | Inquiry | ||
CPM-1-0400 | H-2Kd RSV M2 tetramer-SYIGSINNI-APC labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Phosphoramidon is a kind of thermolysin inhibitor isolated from a culture filtrate of streptomyces. It has prove ...
Studies on the binding affinities of darifenacin hydrobromide and human muscarinic receptor subtypes show strong ...
Teicoplanin is a glycopeptide antibiotic developed after vancomycin for the treatment of Gram-positive (G+) cocc ...
Cyclosporin A (CsA) is a cyclic polypeptide consisting of 11 amino acids, which contains a new amino acid contai ...
Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...